BioCentury
ARTICLE | Company News

Sirenade, Polichem CNS deal

May 10, 2004 7:00 AM UTC

Sirenade (Munich, Germany) received an exclusive license from Polichem (Lugano, Switzerland) to develop a sustained release formulation of dihydroergocryptine (DHEC), a dopamine receptor agonist to tr...